Filler Vascular Occlusion: Warning Signs, Emergency Treatment, and Why Time Is Critical

Vascular occlusion from facial filler is a rare but serious medical emergency. It occurs when hyaluronic acid filler compresses or enters a blood vessel, interrupting blood flow to the tissue supplied by that vessel. If not treated promptly and correctly, it can result in skin necrosis, which means permanent tissue death, and in the most severe cases, vision loss.

This page is written for patients who are experiencing or have experienced concerning symptoms after filler, as well as patients evaluating providers and wanting to understand what safety standards should look like in a filler practice.

If you are experiencing blanching, severe pain, or vision changes after a filler injection right now, call your injector immediately. If you have vision symptoms, call 911.

How Filler Vascular Occlusion Occurs

There are two main mechanisms that can cause filler-related vascular compromise.

Direct Vascular Compression

Filler placed near a blood vessel can place external pressure on that vessel, reducing blood flow through compression of the vessel wall. This is more likely when larger volumes are injected in a concentrated area or when firmer, higher-viscosity products are used.

Compression-type occlusions may respond to hyaluronidase dissolution of the filler deposit that is pressing on the vessel.

Intra-Arterial Injection

A more serious mechanism occurs when filler is inadvertently injected directly into an artery. This can happen if the needle tip enters the vessel or if injection pressure exceeds the vessel’s resistance.

The filler can then act as embolic material, traveling through the arterial system and blocking smaller downstream vessels. This cuts off blood flow to the tissue supplied by those vessels.

In the most severe cases, filler can travel backward through vascular connections into the ophthalmic arterial system and reach the central retinal artery or its branches. This can cause retinal ischemia and permanent vision loss.

High-Risk Anatomical Zones

Certain areas of the face carry higher vascular risk because of the size, depth, and vascular connections of the vessels in those regions.

Glabella: The area between the brows contains the supratrochlear and supraorbital arteries, which have direct connections to the ophthalmic artery. This has historically been one of the most common sites associated with filler-related blindness.
Nose: The dorsal nasal artery has connections with the ophthalmic system, and the alar region has a dense vascular network.
Nasolabial folds: Branches of the facial artery are present in this region, and deeper injections can carry higher risk.
Forehead: The supratrochlear and supraorbital vessels are present here, with increased risk during deep periosteal injection.
Temple: The superficial temporal artery is relevant in this area, especially with larger-volume or high-pressure injection.
Perioral region: The superior and inferior labial arteries are important when treating the lips, philtrum, and surrounding areas.

Warning Signs of Filler Vascular Occlusion

Every patient who has had filler should know the warning signs of a vascular event. Prompt recognition is one of the most important factors in determining the outcome.

Immediate Signs During or Right After Injection

Blanching: Sudden, well-defined white discoloration that extends beyond the injection point. Normal pressure-related blanching resolves within seconds, but vascular blanching persists and may expand.
Disproportionate pain: Some injection discomfort is expected, but severe, burning, or pressure-like pain that does not begin to improve immediately after injection is concerning.
Vision changes: Any blurring, darkening, eye pain, or loss of part of the visual field during or after facial filler injection should be treated as a vision-threatening emergency.

Vision symptoms require emergency department care, not office management.

Delayed Signs Minutes to Hours After Injection

Dusky discoloration: Grayish, purple, or net-like mottled discoloration in the treated area or nearby vascular territory
Progressive skin darkening: Skin that becomes darker over several hours
Pustules or blisters: Blistering in the affected area within 24 to 72 hours can be a sign that tissue necrosis is beginning
Eschar: A dark, dried crust over necrotic skin, which is a late sign of full-thickness skin death

Emergency Treatment for Filler Vascular Occlusion

Vascular occlusion treatment is time-sensitive. A helpful way to understand it is: time is tissue. Every hour of continued reduced blood flow increases the risk of irreversible tissue damage.

Immediate Steps

Stop injecting immediately. The needle should be removed, and no additional filler should be injected in an attempt to “push through” the blockage.
Administer high-dose hyaluronidase. Emergency protocols may require substantially higher doses than elective filler dissolution, with repeated treatment until clinical improvement is seen.
Apply warm compresses and massage. This may help promote vasodilation and spread of hyaluronidase.
Administer aspirin 325 mg when appropriate. Aspirin may be used for its antiplatelet effect.
Apply nitroglycerin paste when appropriate. This may be used topically to help promote vasodilation in the affected area.
Monitor closely and reassess repeatedly. Repeat hyaluronidase may be needed until perfusion improves.

For vision-threatening events, immediate emergency department transfer is required. There is no reliable office-based treatment for intraocular vascular occlusion. Emergency ophthalmology care is needed, but outcomes can be poor once central retinal artery occlusion has occurred.

Why Hyaluronidase Should Be Available in Every Filler Office

A vascular occlusion treated quickly can often be improved or resolved with high-dose hyaluronidase. The same occlusion treated hours later may result in permanent scarring.

This is why hyaluronidase must be immediately available in any office performing hyaluronic acid filler injections. It should not need to be ordered after an emergency or borrowed from another provider.

Dr. Yoo maintains hyaluronidase in the office at all times. When evaluating any injector, it is appropriate to ask: “Do you have hyaluronidase in this office, and do you know the emergency protocol for vascular occlusion?” The answer to both should be yes.

Prevention: How Ultrasound Helps Reduce Vascular Risk

No injection technique can eliminate vascular risk completely, but ultrasound imaging can help reduce risk by identifying the specific course of blood vessels in the patient being treated.

Vascular anatomy varies from person to person. A vessel that runs deep in one patient may be more superficial in another. Ultrasound allows Dr. Yoo to identify vascular location before injection and plan injection angle, depth, and placement more carefully.

Frequently Asked Questions

Q: What are the signs of filler vascular occlusion?

A: Signs can include immediate blanching beyond the injection point, severe or disproportionate pain, or any vision changes during or after filler injection. Delayed signs may include dusky discoloration, a net-like mottled pattern, progressive skin darkening, blistering, or eschar. Any of these symptoms require immediate contact with your injector.

Q: What should I do if I think I have a vascular occlusion?

A: Contact your injector immediately. If you are having any vision symptoms, call 911. Time is critical, and earlier treatment with hyaluronidase is associated with better outcomes.

Q: Can filler cause blindness?

A: Yes, although it is rare. Filler-related blindness can occur if filler enters an artery and travels into the ophthalmic arterial system, blocking blood flow to the retina. High-risk areas include the glabella, nose, nasolabial folds, and forehead. Prevention through safe technique, anatomical knowledge, and appropriate emergency preparedness is essential.

Q: How much hyaluronidase is used to treat vascular occlusion?

A: Emergency treatment uses much higher doses than elective filler dissolution. Published protocols often recommend repeated high-dose hyaluronidase until blood flow improves, and total dosing may be significantly higher than what is used for routine filler correction.

Book a Filler Safety Consultation in Manhattan

Dr. Jane Yoo offers ultrasound-guided filler assessment, filler dissolution, and complication management at her Manhattan dermatology practice. If you are concerned about filler placement, vascular symptoms, or whether your filler should be dissolved, schedule a consultation for a careful evaluation.